First quarter Net Income of $56.7M and Adjusted Net Income of $4.1M Strong execution and early season fire activity drove first quarter Adjusted EBITDA of $18.1M First quarter Earnings Per Diluted ...
The Company continues to gain significant positive commercial market traction with its first U.S. Food and Drug Administration ("FDA")-cleared product, Perimeter S-Series: Q1-2025 revenue of $550,269, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results